The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

Print

[CINP2024] Poster Session

CINP2024 » Poster Session

Schizophrenia 2 -Preclinical

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

[P161] The nitric oxide (NO) donor molsidomine counteract behavioural deficits resembling negative symptoms and cognitive defcits in the rat.

*Nikolaos Pitsikas1, Lamprini Katsanou1, Foteini Vartzoka1 (1. School of Medicine, Faculty of Health Sciences, University of Thessaly)

Keywords:nitric oxide, schizophrenia, molsidomine

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password